According to MeiraGTx's latest financial reports the company's current earnings (TTM) are -$70.79 M. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$79.28 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$70.79 M | -43.22% |
2022 | -$0.13 B | 57.27% |
2021 | -$79.28 M | 37.02% |
2020 | -$57.86 M | 5.77% |
2019 | -$54.7 M | -34.34% |
2018 | -$83.31 M | 168.72% |
2017 | -$31.01 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$19.09 M | -73.04% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$73.07 M | 3.22% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 646.82% | ๐บ๐ธ USA |
Novocure
NVCR | -$0.19 B | 166.20% | Jersey |